The large number of patients with rheumatoid arthritis exposed to placebo or ineffective treatments in clinical trials poses an ethical dilemma for investigators and clinicians. Rheumatologist Dr Sam Whittle, coauthor of a BMJ article calling for transparency around clinical trial design and ethics approvals, said his concern was for patients unduly deprived of effective treatment. ...
Clinical trials not always benign for patients who volunteer
By Mardi Chapman
22 Sep 2016